内质网
细胞生物学
未折叠蛋白反应
衰老
程序性细胞死亡
细胞凋亡
生物
PI3K/AKT/mTOR通路
生物发生
细胞
细胞生长
癌症研究
信号转导
遗传学
基因
作者
Carlos Anerillas,Krystyna Mazan-Mamczarz,Allison B. Herman,Rachel Munk,Gabriel K. Y. Lam,Miguel Calvo‐Rubio,Amanda Garrido,Dimitrios Tsitsipatis,Jennifer L. Martindale,Gisela Altés,Martina Rossi,Yulan Piao,Jinshui Fan,Chang‐Yi Cui,Supriyo De,Kotb Abdelmohsen,Rafael de Cabo,Myriam Gorospe
标识
DOI:10.1101/2022.12.18.520921
摘要
ABSTRACT Sublethal cell damage can trigger a complex adaptive program known as senescence, characterized by growth arrest, resistance to apoptosis, and a senescence-associated secretory phenotype (SASP). As senescent cells accumulating in aging organs are linked to many age-associated diseases, senotherapeutic strategies are actively sought to eliminate them. Here, a whole-genome CRISPR knockout screen revealed that proteins in the YAP-TEAD pathway influenced senescent cell viability. Accordingly, treating senescent cells with a drug that inhibited this pathway, Verteporfin (VPF), selectively triggered apoptotic cell death and derepressed DDIT4, in turn inhibiting mTOR. Reducing mTOR function in senescent cells diminished endoplasmic reticulum (ER) biogenesis, causing ER stress and apoptosis due to high demands on ER function by the SASP. Importantly, VPF treatment decreased senescent cell numbers in the organs of old mice and mice exhibiting doxorubicin-induced senescence. We present a novel senolytic strategy that eliminates senescent cells by hindering ER activity required for SASP production.
科研通智能强力驱动
Strongly Powered by AbleSci AI